Search Results

There are 13552 results for: content related to: Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

  1. You have free access to this content
    Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma


    Volume 120, Issue 5, 1 March 2014, Pages: 692–701, Petros D. Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn A. Bylow, Steven G. Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al-Hawary, David C. Smith and Maha Hussain

    Article first published online : 18 NOV 2013, DOI: 10.1002/cncr.28477

  2. You have free access to this content
    Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma


    Volume 118, Issue 5, 1 March 2012, Pages: 1252–1259, Carlos H. Barrios, David Hernandez-Barajas, Michael P. Brown, Se-Hoon Lee, Luis Fein, Jin-Hwang Liu, Subramanian Hariharan, Bridget A. Martell, Jinyu Yuan, Akintunde Bello, Zhixiao Wang, Rajiv Mundayat and Sun-Young Rha

    Article first published online : 6 SEP 2011, DOI: 10.1002/cncr.26440

  3. You have free access to this content
    Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy

    International Journal of Cancer

    Volume 130, Issue 8, 15 April 2012, Pages: 1948–1959, Benedetto Farsaci, Jack P. Higgins and James W. Hodge

    Article first published online : 8 AUG 2011, DOI: 10.1002/ijc.26219

  4. You have free access to this content
    A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061


    Volume 120, Issue 8, 15 April 2014, Pages: 1194–1202, Michelle A. Rudek, Page C. Moore, Ronald T. Mitsuyasu, Bruce J. Dezube, David Aboulafia, John Gerecitano, Ryan Sullivan, Mary E. Cianfrocca, David H. Henry, Lee Ratner, Missak Haigentz, Afshin Dowlati, Richard F. Little, Susan Percy Ivy and John F. Deeken

    Article first published online : 28 JAN 2014, DOI: 10.1002/cncr.28554

  5. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Article first published online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  6. Targeted therapy for advanced renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Chris Coppin, Lyly Le, Timothy J Wilt and Christian Kollmannsberger

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006017.pub2

  7. You have full text access to this OnlineOpen article
    Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment

    Cancer Science

    Volume 106, Issue 2, February 2015, Pages: 160–170, Gökçe Hatipoglu, Stefan W. Hock, Ruth Weiss, Zheng Fan, Tina Sehm, Ali Ghoochani, Michael Buchfelder, Nicolai E. Savaskan and Ilker Y. Eyüpoglu

    Article first published online : 15 FEB 2015, DOI: 10.1111/cas.12580

  8. Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment-use trial of sunitinib


    Volume 121, Issue 9, May 1, 2015, Pages: 1405–1413, Peter Reichardt, Yoon-Koo Kang, Piotr Rutkowski, Jochen Schuette, Lee S. Rosen, Beatrice Seddon, Suayib Yalcin, Hans Gelderblom, Charles C. Williams Jr, Elena Fumagalli, Guido Biasco, Herbert I. Hurwitz, Pamela E. Kaiser, Kolette Fly, Ewa Matczak, Liang Chen, Maria José Lechuga and George D. Demetri

    Article first published online : 13 JAN 2015, DOI: 10.1002/cncr.29220

  9. You have free access to this content
    PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines

    International Journal of Cancer

    Volume 131, Issue 2, 15 July 2012, Pages: E45–E55, Claus Bender and Axel Ullrich

    Article first published online : 28 FEB 2012, DOI: 10.1002/ijc.26486

  10. You have free access to this content
    Sunitinib-induced hyperparathyroidism


    Volume 118, Issue 12, 15 June 2012, Pages: 3165–3172, Valentina Baldazzi, Renato Tassi, Alberto Lapini, Alice Lunghi, Eleonora Garofoli, Salvatore Caruso, Marco Carini and Roberto Mazzanti

    Article first published online : 28 SEP 2011, DOI: 10.1002/cncr.26435

  11. You have free access to this content
    Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

    International Journal of Cancer

    Volume 134, Issue 7, 01 April 2014, Pages: 1695–1705, Ritika Jaini, Patricia Rayman, Peter A. Cohen, James H. Finke and Vincent K. Tuohy

    Article first published online : 8 OCT 2013, DOI: 10.1002/ijc.28488

  12. Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders

    British Journal of Pharmacology

    Volume 171, Issue 24, December 2014, Pages: 5757–5773, Wolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, Emily Stocking, Valentina L Kouznetsova, Diana Price, Amy Paulino, Tania Gonzales, Cassia R Overk, Christina Patrick, Edward Rockenstein and Eliezer Masliah

    Article first published online : 1 DEC 2014, DOI: 10.1111/bph.12875

  13. You have free access to this content
    A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer


    Volume 115, Issue 4, 15 February 2009, Pages: 776–783, Daniel Y. C. Heng, Kim N Chi, Nevin Murray, Tao Jin, Jorge A Garcia, Ronald M Bukowski, Brian I Rini and Christian Kollmannsberger

    Article first published online : 6 JAN 2009, DOI: 10.1002/cncr.24051

  14. Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro

    Diseases of the Esophagus

    Y.-Q. Ding, H.-C. Zhu, X.-C. Chen, X.-C. Sun, X. Yang, Q. Qin, H. Zhang, Y. Yang, Y.-H. Yang, L. Gao, J.-D. Luo and X.-F. Zhou

    Article first published online : 6 NOV 2015, DOI: 10.1111/dote.12440

  15. You have full text access to this OnlineOpen article
    Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1003–1015, Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman and Victor L. Thijssen

    Article first published online : 31 MAR 2015, DOI: 10.1002/cam4.441

  16. You have free access to this content
    Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

    Asia-Pacific Journal of Clinical Oncology

    Volume 3, Issue 4, December 2007, Pages: 167–176, Jayesh DESAI, Howard GURNEY, Nick PAVLAKIS, Grant A McARTHUR and Ian D DAVIS

    Article first published online : 3 DEC 2007, DOI: 10.1111/j.1743-7563.2007.00136.x

  17. Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 809–819, Huixin Yu, Neeltje Steeghs, Jacqueline S. L. Kloth, Djoeke de Wit, J. G. Coen van Hasselt, Nielka P. van Erp, Jos H. Beijnen, Jan H. M. Schellens, Ron H. J. Mathijssen and Alwin D. R. Huitema

    Article first published online : 22 APR 2015, DOI: 10.1111/bcp.12550

  18. You have free access to this content
    Using the Rasch Model to Validate and Enhance the Interpretation of the Functional Assessment of Cancer Therapy–Kidney Symptom Index—Disease-Related Symptoms Scale

    Value in Health

    Volume 12, Issue 4, June 2009, Pages: 580–586, Xuemei Luo, Joseph C. Cappelleri, David Cella, Jim Z. Li, Claudie Charbonneau, Sindy T. Kim, Isan Chen and Robert J. Motzer

    Article first published online : 11 NOV 2008, DOI: 10.1111/j.1524-4733.2008.00473.x

  19. You have free access to this content
    Sunitinib Produces Neuroprotective Effect Via Inhibiting Nitric Oxide Overproduction

    CNS Neuroscience & Therapeutics

    Volume 20, Issue 3, March 2014, Pages: 244–252, Wei Cui, Zai-Jun Zhang, Sheng-Quan Hu, Shing-Hung Mak, Da-Ping Xu, Chung-Lit Choi, Yu-Qiang Wang, Wah-Keung Tsim, Ming-Yuen Lee, Jian-Hui Rong and Yi-Fan Han

    Article first published online : 7 JAN 2014, DOI: 10.1111/cns.12203

  20. Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells

    The Prostate

    Volume 75, Issue 11, August 1, 2015, Pages: 1137–1149, Roque Diaz, Paul A. Nguewa, Miriam Redrado, Irene Manrique and Alfonso Calvo

    Article first published online : 20 APR 2015, DOI: 10.1002/pros.22980